Status:

COMPLETED

Maternal Morbidity and Mortality During the COVID-19 Pandemic

Lead Sponsor:

The George Washington University Biostatistics Center

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

COVID-19

Pregnancy Complications

Eligibility:

FEMALE

Brief Summary

A cohort study of women who deliver at select sites on randomly selected days in 2019 and 2020, and all confirmed COVID-19 infections among pregnant or immediately postpartum women in 2020. The study ...

Detailed Description

This cohort study includes women who deliver at one of the MFMU Network hospitals on randomly selected days between March 1 and December 31, 2019 and March 1 and December 31, 2020 to evaluate the effe...

Eligibility Criteria

Inclusion

  • Women who deliver at a selected hospital participating in the MFMU Network on selected dates sent by the Data Coordinating Center from March 1, 2019, through Dec, 31, 2019. Women delivered in the calendar year 2019 will serve as the controls (before pandemic).
  • Women who deliver at a selected hospital participating in the MFMU Network on selected dates sent by the Data Coordinating Center from March 1, 2020, through Dec, 31, 2020. Women delivered in the calendar year 2020 will be considered as deliveries during the pandemic (research question 1) and non-confirmed positives as controls (research question 2).
  • Pregnant and postpartum (within 6 weeks of delivery) women with confirmed COVID-19 infection from March 1, 2020, through Dec, 31, 2020 and who deliver on or before December 31, 2020. Both those with COVID-19 infection requiring in-patient management and those managed as out-patients will be included. Confirmed COVID-19 infection is defined as a positive COVID-19 viral (i.e., nucleic acid or antigen tests) test during pregnancy through 42 days postpartum.

Exclusion

  • Multifetal gestation higher than twins

Key Trial Info

Start Date :

June 23 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 4 2021

Estimated Enrollment :

25604 Patients enrolled

Trial Details

Trial ID

NCT04519502

Start Date

June 23 2020

End Date

November 4 2021

Last Update

March 27 2023

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

University of Alabama - Birmingham

Birmingham, Alabama, United States, 35233

2

Northwestern University

Chicago, Illinois, United States, 60611

3

Columbia University-St. Luke's Hospital

New York, New York, United States, 10032

4

University of North Carolina-Chapel Hill

Chapel Hill, North Carolina, United States, 17599